Category Archives: News

Biomarker research: The maintained attention assessment in patients affected by ME/CFS

Posted on 12/09/2021 by wames

The maintained attention assessment in patients affected by Myalgic encephalomyelitis/ chronic fatigue syndrome: A reliable biomarker?, by Inigo Murga, Larraitz Aranburu, Pascual A Gargiulo, Juan-Carlos Gomez-Esteban, Jose-Vicente Lafuente in Journal of Translational Medicine Vol 19, #1, p 494, December 4, 2021 … Continue reading →

Posted in News | Tagged , , , , , , , | Comments Off on Biomarker research: The maintained attention assessment in patients affected by ME/CFS

Hidden from sight: why the complexity of ME/CFS needs to be recognised by policy makers

Posted on 12/09/2021 by wames

Hidden from Sight: Why the complexity of ME/CFS needs to be recognised by policy makers, by Tomruk Ustunkaya and Richard Machin, by People, Place and Policy Vol 15, #2, pp. 91-99, November 2021   Background: An estimated 260,000 people in the UK … Continue reading →

Posted in News | Tagged , , , , , , , | Comments Off on Hidden from sight: why the complexity of ME/CFS needs to be recognised by policy makers

Subgroup research: Tryptophan metabolites, cytokines & FAPB-2 in ME/CFS

Posted on 12/08/2021 by wames

Tryptophan metabolites, cytokines, and fatty acid binding protein 2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by Manuela Simonato, Stefano Dall’Acqua, Caterina Zilli, Stefania Sut, Romano Tenconi, Nicoletta Gallo, Paolo Sfriso, Leonardo Sartori, Francesco Cavallin, Ugo Fiocco, Paola Cogo, Paolo Agostinis, Anna … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , , , , , | Comments Off on Subgroup research: Tryptophan metabolites, cytokines & FAPB-2 in ME/CFS

Raise funds for WAMES by shopping with an Amazon smile!

Posted on 12/01/2021 by wames

You shop. Amazon gives, with a smile.  Choose WAMES!   AmazonSmile is the same Amazon you know. Same products, same prices, same service. Shop at smile.amazon.co.uk and they will donate to your favourite charitable organisation, at no cost to you. Go to … Continue reading →

Posted in News | 1 Comment

Research: Limbic perfusion is reduced in patients with ME/CFS

Posted on 11/26/2021 by wames

Limbic perfusion is reduced in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), by Xia Li, Per Julin and Tie-Qiang Li in Tomography 2021, 7(4), 675-687; [doi.org/10.3390/tomography7040056] 1 Nov 2021   Research abstract: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an illness … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: Limbic perfusion is reduced in patients with ME/CFS

Research: Analysis of post COVID-19 & its overlap with ME/CFS

Posted on 11/25/2021 by wames

Long COVID overlap with ME/CFS   A group of researchers from around the world have joined together to analyse long COVID’s symptom overlap with ME/CFS. Highlights Serious side effects and post-infection sequelae have been reported in SARS-CoV-2-infected patients after acute … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Research: Analysis of post COVID-19 & its overlap with ME/CFS

Hypothesis: An attempt to explain the neurological symptoms of ME/CFS

Posted on 11/24/2021 by wames

An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome, by Klaus J Wirth, Carmen Scheibenbogen & Friedemann Paul in Journal of Translational Medicine volume 19, no: 471 (2021)   Review abstract There is accumulating evidence of endothelial … Continue reading →

Posted in News | Tagged , , , , , , , | Comments Off on Hypothesis: An attempt to explain the neurological symptoms of ME/CFS

Research: Understanding the molecular changes of PEM in ME/CFS

Posted on 11/22/2021 by wames

Understanding the molecular changes of Post Exertional Malaise in ME/CFS,  by Jemma Elley (Thesis, Bachelor of Biomedical Sciences with Honours). University of Otago, 2021   Research abstract: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating and often life-long condition affecting … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Research: Understanding the molecular changes of PEM in ME/CFS

Research review: Immunoglobulin therapy for ME/CFS

Posted on 11/15/2021 by wames

Back to the Future? Immunoglobulin therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by  Helen Brownlie and Nigel Speight in Healthcare 2021, 9(11), 1546; [doi.org/10.3390/healthcare9111546]   12 Nov 2021 (This article belongs to the Special Issue ME/CFS – the Severely and Very Severely Affected)   … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Research review: Immunoglobulin therapy for ME/CFS

Research: The characterization of IL-2 stimulation & treatment of TRPM3… in ME/CFS

Posted on 11/15/2021 by wames

Characterization of IL-2 stimulation and TRPM7 pharmacomodulation in NK Cell cytotoxicity and channel Co-Localization with PIP2 in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome patients, by Stanley Du Preez , Natalie Eaton-Fitch, Helene Cabanas, Donald Staines and Sonya Marshall-Gradisnik in Int. J. … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: The characterization of IL-2 stimulation & treatment of TRPM3… in ME/CFS